Parkinson’s disease is mostly known for motor control problems, but a significant number of patients who have the condition also experience cognitive decline.
A new study from University of Arizona researchers shows there may be a path to treatment.
The key is a protein called PNA5. The study showed treatments with the protein reversed cognitive dysfunction in mice by using object recognition and mazes.
It was able to do so by targeting inflammation in the brain. While inflammation is part of the immune system’s response to fight infections, there’s potential for harm.
“It can also become maladaptive in certain situations and that's kind of what happens in Parkinson's disease is that these immune cells called microglia are in fact have become maladaptive, and they go into the supercharge state we call it," said UA professor and study co-author Lalitha Madhavan.
She said she’s hopeful, as a similar drug using the protein is also in clinical trials treating vascular dementia. The study was published in the journal Experimental Neurology.
-
Some medical professionals and industry observers are starting to notice a troubling trend among heavy cannabis users: marijuana-induced psychosis. -
Calling your doctor "doctor" really matters in medicine. KJZZ's medical commentator, Dr. Joseph Sirven explains. -
The Peoria Unified School District will cut all of its social workers at the end of this year, as funds from the state’s school safety grant program will run out. -
ACA enrollment across the U.S. has plummeted since Republicans refused to extend Affordable Care Act tax credits. -
Former first lady Rosalynn Carter once said there are four kinds of people in the world: “those who have been caregivers, those who are currently caregivers, those who will be caregivers and those who will need caregivers." But there might be a fifth: caregivers who help other caregivers.
